Arf1 inhibition induces tumor regression by promoting T cell infiltration

[News]

In recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have been highly successful and have become an important basis for the future treatment of cancers.

More... (https://www.news-medical.net/news/20230912/Arf1-inhibition-induces-tumor-regression-by-promoting-T-cell-infiltration.aspx)